Canada to ship experimental Ebola vaccine to WHO in Geneva | Canada | Reuters.
TORONTO (Reuters) – The Canadian government will ship 800 vials of its experimental Ebola vaccine to the World Health Organization in Geneva beginning on Monday, the Public Health Agency of Canada said on Saturday.
The WHO, in consultation with health authorities in the countries most affected by the outbreak of the disease, will decide on how the vaccine will be distributed and used, the agency said in a statement.
The vaccine is undergoing clinical trials on humans at Walter Reed Army Institute of Research in the United States after showing promising results in animal testing, it said.
The Canadian government said in August it would donate between 800 and 1,000 doses of its VSV-EBOV vaccine to the WHO for use in Africa, but the vaccine remained in a government lab as Canadian and WHO officials grappled with logistical and ethical issues.
